Tivity Health (NASDAQ:TVTY) shares traded -1.86% down during most recent session to reach at the closing price of $17.93. The stock exchanged hands 849494 shares versus average trading capacity of 1.11 Million shares, yielding a market cap of $736.39 Million. Wall Street analysts covering the stock are projecting that the stock will reach $32.86 within the next 52-weeks. The mean target projections are based on 7 opinions.
Taking a broader look brokerage firms’ analysts on the street with an expectant view have Tivity Health (NASDAQ:TVTY) high price target of $40 and with a conservative view have low price target of $28.
Cantor Fitzgerald “Maintained” Tivity Health (NASDAQ:TVTY) in a research note issued to investors on 12/17/18 to Overweight with price target of $49.
Additionally on 6/04/18 Chardan Capital “Upgrades” Tivity Health (NASDAQ:TVTY) to Buy setting price target at $0 and on 2/23/18 Chardan Capital “Maintained” the stock to Neutral at $41. Furthermore on 11/01/17 Oppenheimer “Maintained” the stock to Outperform at $50.
On the other hand the company has Relative Strength Index (RSI 14) of 16.64 along with Average True Range (ATR 14) of 0.76, Consequently Tivity Health (NASDAQ:TVTY)’s weekly and monthly volatility is 3.65%, 4.14% respectively. The company’s beta value is at 1.07.
In terms of Buy, Sell or Hold recommendations, Tivity Health (NASDAQ:TVTY) has analysts’ mean recommendation of 0. This is according to a simplified 1 to 5 scale where 1 represents a Strong Buy and 5 a Strong Sell.
According to analysts Tivity Health (NASDAQ:TVTY)’s minimum EPS for the current quarter is at $0.47 and can go high up to $0.57. The consensus mean EPS for the current quarter is at $0.54 derived from a total of 5 estimates from the analysts who have weighed in on projected earnings. However the company reported $0.49 earnings per share for the same quarter during last year.
Previously Tivity Health (NASDAQ:TVTY) reported $0.73 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.58 by $0.15. The company posted an earnings surprise of 25.9%.
Tivity Health (NASDAQ:TVTY)’s revenue estimates for the current quarter are $153.92 Million according to 5 number of analysts, for the current quarter the company has high revenue estimates of $156.2 Million in contradiction of low revenue estimates of $151.4 Million. For the current year the company’s revenue estimates are $619.99 Million compared to low analyst estimates of $618 Million and high estimates of $624.19 Million according to 5 number of analysts.
Currently Tivity Health (NASDAQ:TVTY)’s shares owned by insiders are 0.8%, whereas shares owned by institutional owners are 0%. However the six-month change in the insider ownership was recorded -9.63%, as well as three-month change in the institutional ownership was recorded -11.13%.
Tivity Health (NASDAQ:TVTY)’s trailing twelve month revenues are $606.3 Million, whereas its price to sales ratio for the same period is 1.21. Its book value per share for the most recent quarter is $9.08 while its price to book ratio for the same period is 1.97, as for as the company’s cash per share for the most recent quarter is $0.05, however its price to cash per share ratio for the same period is 387.57. The stock has 5 year expected PEG ratio of 0.79 whereas its trailing twelve month P/E ratio is 7.88.